News Ticker

Immunoassay

Biosurfit 500 spinit® Instruments

April 17, 2017

Biosurfit SA (“biosurfit”), the in vitro point-of-care (PoC) diagnostics company, is pleased to announce that it has reached a significant commercial milestone, and also provides an update on recent progress. At the end of February [more...]

Biotech Firm Raises $17 Million in Financing Round

January 22, 2017

Adarza BioSystems Inc., a Henrietta-based company, has raised $17 million in its Series C financing round, officials said Friday.  3×5 RiverVest Fund II L.P. is the lead investor for the round. It is co-managed by a joint venture [more...]

Rainbow Seed Fund Invests in AgPlus Diagnostics

October 2, 2016

Rainbow Seed Fund, an early-stage venture capital fund focused on promising technologies developed at the UK’s largest publicly funded research facilities and campuses, today announces its investment into AgPlus Diagnostics, a technology [more...]

Biosensia

September 16, 2014

Biosensia is an in vitro diagnostics company that has developed a novel point of care platform, RapiPlex. Biosensia’s proprietary RapiPlex platform integrates three technologies: A multi-channel fluidic chip Robust, well-established [more...]